about
Galleria mellonella as a model host to study infection by the Francisella tularensis live vaccine strainAntifungal chemical compounds identified using a C. elegans pathogenicity assayWhole animal automated platform for drug discovery against multi-drug resistant Staphylococcus aureusRepurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureusIdentification of an Antimicrobial Agent Effective against Methicillin-Resistant Staphylococcus aureus Persisters Using a Fluorescence-Based Screening StrategyA Defensin from the Model Beetle Tribolium castaneum Acts Synergistically with Telavancin and Daptomycin against Multidrug Resistant Staphylococcus aureusNH125 kills methicillin-resistant Staphylococcus aureus persisters by lipid bilayer disruption.The temperature-sensitive role of Cryptococcus neoformans ROM2 in cell morphogenesis.Prokaryote-eukaryote interactions identified by using Caenorhabditis elegansCaenorhabditis elegans-based model systems for antifungal drug discovery.Role of filamentation in Galleria mellonella killing by Candida albicansMolecular and nonmolecular diagnostic methods for invasive fungal infections.Oral Candida albicans isolates from HIV-positive individuals have similar in vitro biofilm-forming ability and pathogenicity as invasive Candida isolates.Selecting an invertebrate model host for the study of fungal pathogenesis.Effect of virulence factors on the photodynamic inactivation of Cryptococcus neoformans.Insect-derived cecropins display activity against Acinetobacter baumannii in a whole-animal high-throughput Caenorhabditis elegans modelA multi-host approach for the systematic analysis of virulence factors in Cryptococcus neoformans.The role of Candida albicans SPT20 in filamentation, biofilm formation and pathogenesis.Competitive Interactions between C. albicans, C. glabrata and C. krusei during Biofilm Formation and Development of Experimental Candidiasis.Lactobacillus paracasei modulates the immune system of Galleria mellonella and protects against Candida albicans infectionMicafungin Elicits an Immunomodulatory Effect in Galleria mellonella and Mice.Antibacterial properties of 3-(phenylsulfonyl)-2-pyrazinecarbonitrileUsing non-mammalian hosts to study fungal virulence and host defense.Generation of composite plants using Agrobacterium rhizogenes.Galleria mellonella are resistant to Pneumocystis murina infection.The role of mycelium production and a MAPK-mediated immune response in the C. elegans-Fusarium model systemOur paths might cross: the role of the fungal cell wall integrity pathway in stress response and cross talk with other stress response pathways.Polymerase chain reaction-based assays for the diagnosis of invasive fungal infections.Nonmammalian model systems to investigate fungal biofilms.Activity of a novel protonophore against methicillin-resistant Staphylococcus aureus.Raf-kinase inhibitor GW5074 shows antibacterial activity against methicillin-resistant Staphylococcus aureus and potentiates the activity of gentamicin.Correlation between Candida albicans biofilm formation and invasion of the invertebrate host Galleria mellonella.The salivary microbiome is consistent between subjects and resistant to impacts of short-term hospitalization.Heterocycle Thiazole Compounds Exhibit Antifungal Activity through Increase in the Production of Reactive Oxygen Species in the Cryptococcus neoformans-Cryptococcus gattii Species Complex.Synergistic Efficacy of Aedes aegypti Antimicrobial Peptide Cecropin A2 and Tetracycline against Pseudomonas aeruginosa.Repurposing niclosamide as a versatile antimicrobial surface coating against device-associated, hospital-acquired bacterial infections.Candida parapsilosis Resistance to Fluconazole: Molecular Mechanisms and In Vivo Impact in Infected Galleria mellonella Larvae.Innate recognition of cell wall β-glucans drives invariant natural killer T cell responses against fungi.Methods for using Galleria mellonella as a model host to study fungal pathogenesis.Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform.
P50
Q24684708-49943056-CC2C-4382-9A01-FFA5CACB66C2Q28469125-0B41F8D8-E6A7-433F-AAB0-96699B9A68EBQ28539903-1DB47FC5-498E-41F9-B94A-85BC3D375FADQ28546591-A1F87C31-8F5C-4AEE-984E-8A9A1E7994ABQ28547787-23F8469A-FF66-4F4A-B18B-D79B38B4FE6FQ28548126-7A9C0D8E-AF70-4541-B523-1AF21CF79192Q30795809-5E4C1276-40E1-4B03-8847-D4447487CBA3Q33281756-56109373-905E-497F-88CD-CB1130328C58Q33369708-C7946AC4-DF8B-47E7-AF02-3BBA98676139Q33864072-FA44BC78-5E5B-498A-966B-24EC1D54F439Q33905903-04212535-51A1-4FB6-995C-1FE216695303Q34057660-579F9BB6-11C1-4125-B925-30C6CC62A807Q34067285-A42E25C4-B47A-4984-8E06-DBCF369B5963Q34154456-C0312FEC-09A3-4B9E-B580-6C987E8D1ADBQ34563021-8040A3A0-74E5-47AA-A6DC-CC4DCC2E0A0FQ35076900-BD4E2463-132F-4764-8256-9D5024E4A291Q35127316-4D4D20ED-3600-47CC-9DE7-4D62EF35A9C8Q35147589-5417ADF8-06AF-4072-9561-41BDCA3894C7Q35683105-51CB077A-400F-4A44-B39C-D4C5CE43CC41Q36299538-086DD611-59EA-4507-BEAC-DDF6D7C8A6CCQ36365889-15AEA12D-17F2-4FDC-A233-0C0348328C41Q36479306-BB3B6F9A-F669-4D50-B89C-3C41BDD497D7Q36524854-D34C22A2-D361-43A5-B9BB-EDFEF5D2C26DQ36599459-668A11A3-BAF9-4823-91F4-4F9D9744BD24Q36790678-DA3B653E-31AC-4988-9A05-EA51211F08EAQ37139366-8359EB96-2B71-4281-9D8E-99E1D13CB141Q37410110-0D87468E-F25A-4066-9E2D-F8EB19D13595Q37987893-C2A261ED-DC4C-4694-A164-47ADEE233809Q38199057-624B0B82-8999-4F35-A15E-17443F2E71FEQ38647694-148FD705-4E54-4408-8F01-E907E3FDB88EQ38819114-562E5253-D7C9-490D-AFA6-153B5957C557Q39244556-265CBA2A-1FC0-47BF-8619-82864B8EE8AFQ40059549-08FB9819-BD15-43E6-84CC-0774B702FD12Q40202904-214414AD-44F5-4C07-AB48-7F4C51A11B86Q40220923-9371878D-2588-4CFF-AFA0-FE4F865A698FQ40226784-D2695CBF-7FA7-4820-AAC1-56AEA23C744DQ40640348-98EBC7AD-BED1-475E-96C5-83C55ED0554CQ41045120-1F99ABBC-12AB-49F7-8817-E6ECB93A21B0Q42018667-378A9A9E-0B82-4162-B82F-478212B75EDBQ42129565-1161D2FB-E7D7-4FB0-980E-ECC7FE8EB6CE
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Beth Burgwyn Fuchs
@ast
Beth Burgwyn Fuchs
@en
Beth Burgwyn Fuchs
@es
Beth Burgwyn Fuchs
@nl
type
label
Beth Burgwyn Fuchs
@ast
Beth Burgwyn Fuchs
@en
Beth Burgwyn Fuchs
@es
Beth Burgwyn Fuchs
@nl
prefLabel
Beth Burgwyn Fuchs
@ast
Beth Burgwyn Fuchs
@en
Beth Burgwyn Fuchs
@es
Beth Burgwyn Fuchs
@nl
P106
P31
P496
0000-0001-5233-1221